slides · global inventory
Show Traction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 11,828
Current window 6,871-6,900
Pages 395
Rows per page 30
Slide function
6,871-6,900 of 11,828
06
The timeline is divided into three strategic phases: Establishing the Brand, Transforming to E-Commerce, and Scaling.1stDibs | Investor Presentation Deck | 13 slides · 1stDibs
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
07
The slide uses a grid layout to present 10 distinct KPIs.1stDibs | Investor Presentation Deck | 13 slides · 1stDibs
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
08
The slide uses donut charts to represent the changing proportion of GMV between 'Vintage & Antique' and 'Other Verticals' from inception to 2022.1stDibs | Investor Presentation Deck | 13 slides · 1stDibs
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
11
The slide uses a consistent color-coded legend for each metric across three distinct charts.1stDibs | Investor Presentation Deck | 13 slides · 1stDibs
Pitch deck Investor relations Beat · Financials1 hit
04
The slide highlights the pipeline progress for ABCL575 and ABCL635.AbCellera | Investor Presentation Deck | 16 slides · AbCellera
Pitch deck Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
05
Slide highlights Q3 2023 business update regarding partnership traction.AbCellera | Investor Presentation Deck | 16 slides · AbCellera
Pitch deck Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
08
The slide uses stacked bar charts to distinguish between programs with and without downstream participation.AbCellera | Investor Presentation Deck | 16 slides · AbCellera
Pitch deck Investor relations Beat · SatisfactionLoop · So What Cascade1 hit
09
The slide highlights a new addition (NBL-028) with a green highlight.AbCellera | Investor Presentation Deck | 16 slides · AbCellera
Pitch deck Investor relations Beat · SatisfactionLoop · So What Cascade1 hit
19
The chart displays dose-dependent exposure over 24 hours, with horizontal dashed lines representing efficacy targets for different ROS1 variants in CNS and periphery.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
21
Clinical trial data visualization (waterfall plot) with patient-level characteristics table below.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
22
Swimmer plot showing patient-level treatment duration, response status, and ongoing treatment status.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
23
Includes a spider plot (target lesion change) and a bar chart (allele clearance).Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
24
Includes patient case study with longitudinal MRI scans.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
27
Includes clinical trial data cut-offs and patient enrollment numbers.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
28
The slide details specific patient cohorts (2a-2e) with varying treatment histories and trial objectives.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
32
The slide uses a split-panel layout to contrast in vitro IC50 data with in vivo tumor regression data.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
39
The chart displays patient-level data categorized by dose (15mg to 200mg) and mutation type, highlighting the efficacy of the drug in clearing specific ALK mutations.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
40
The slide presents clinical trial data for NVL-655, showing efficacy across different resistance mutation profiles and prior treatment histories.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
41
Clinical trial data visualization showing ORR and best percentage change in target lesions.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
42
The chart is a swimmer plot, a standard visualization in oncology clinical trials to show time-to-event data for individual patients.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
43
Includes two patient case studies with MRI scans showing tumor reduction.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
05
Snap Inc | Investor Presentation Deck | 50 slidesSnap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations Beat · Traction1 hit
06
The chart displays consistent growth across all three regions over 19 quarters.Snap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations Beat · Traction1 hit
10
The chart uses a cumulative area/line hybrid to visualize growth while annotating product launches chronologically.Snap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations Beat · Traction1 hit
16
The slide uses a combination of a metric-focused yellow card and visual product screenshots to demonstrate traction.Snap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations Beat · Traction1 hit
22
The slide uses screenshots of the Snapchat interface to demonstrate content consumption.Snap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations Beat · Market Sizing1 hit
25
Snap Inc | Investor Presentation Deck | 50 slidesSnap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations Beat · Market Sizing1 hit
31
The slide uses flag icons to represent the countries where this penetration is achieved.Snap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
41
Includes footnotes defining DAU and Adjusted Gross Profit/Margin.Snap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations Beat · Action1 hit
42
Includes footnotes defining non-GAAP measures and specific 2022/2020 adjustments.Snap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations Beat · Action1 hit